[Prune-belly syndrome and therapeutic problems]

Irena Wikiera-Magott1, Magdalena Naleśniak, Anna Jakubowska

  • 1Katedra i Klinika Nefrologii Pediatrycznej Akademii Medycznej im. Piastów Slaskich we Wrocławiu.

Insights

Prune-Belly syndrome (PBS) management requires early prenatal diagnosis and intervention to prevent kidney damage. Multistage surgical therapy can improve outcomes for affected children.

Area of Science:

  • Pediatric Surgery
  • Urology
  • Medical Genetics

Background:

  • Prune-Belly syndrome (PBS) is a congenital disorder characterized by abdominal muscle deficiency, urinary tract abnormalities, and cryptorchidism.
  • Early diagnosis, often prenatal, is crucial for managing PBS and mitigating potential complications.

Observation:

  • This study presents the disease progression and therapeutic challenges in four boys diagnosed with PBS.
  • Prenatal diagnosis was achieved in three cases, with interventions including amniotic fluid supplementation and an abdominal-amniotic shunt.
  • Delivery methods varied, with two born naturally and two via cesarean section at 31 weeks due to intrauterine infection risk.

Findings:

  • Postnatal observations revealed urinary infections and renal function issues in all patients.
  • Surgical interventions included percutaneous nephrostomy, cutaneocystostomy, and orchidopexy.
  • One patient died, and two experienced chronic kidney disease (II degree).

Implications:

  • Children with PBS necessitate ongoing, multidisciplinary medical care.
  • Staged surgical treatment is vital for preserving renal function and enhancing the quality of life for individuals with PBS.
Abstract

Related Concept Videos

Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Bulimia Nervosa01:30

Bulimia Nervosa

Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Pyloric Obstruction01:11

Pyloric Obstruction

Pyloric obstruction, also referred to as gastric outlet obstruction, is a condition characterized by narrowing or blockage at the pylorus—the muscular valve regulating the flow of stomach contents into the duodenum. When this passage becomes impaired, the stomach cannot effectively empty its contents into the small intestine. This disruption leads to a range of gastrointestinal symptoms, including early satiety, bloating, epigastric pain, postprandial nausea, persistent vomiting, and...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...